Mapi Pharma to build sterile injectable production plant in Jerusalem

Mapi Pharma signed a long-term lease at Har-Hotzvim Hi-Tech Park in Jerusalem for a new sterile production plant for GA Depot injectable products. The ~50,000 sq ft facility was previously an FDA-approved facility of Omrix Biopharmaceuticals. Investment in equipment is approximately $13 million, partially funded by a $2.5 million grant.

“Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company announced today that is has signed a long term lease agreement at the Har-Hotzvim Hi-Tech Park in Jerusalem for the establishment of a new sterile production plant for GA Depot injectable products.”einpresswire.com

• 1 source
• einpresswire.comMapi Pharma to Build a New Sterile Injectable Production Plant for GA Depot in JerusalemJul 15, 2019

Summarized from public sources; check the original articles before acting on it.